Q&A

European Compassionate Use Programs: What Are The Quality And Distribution Considerations?

Source: PCI Clinical Services

Compassionate use supplies in Europe are unlicensed medicines and not traditional clinical trial supply. As such the quality and distribution considerations are different for compassionate use supplies in Europe. This article will provide an overview on:

  • QP requirements & expectations
  • Importing compassionate use medicines into the UK & EU
  • Relabeling of compassionate use material
  • The role of the healthcare physician
  • Bona Fide checks
  • Compassionate use supply distribution

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader